Circulating metabolites and coronary heart disease: a bidirectional Mendelian randomization

Area of Science:

• Genetics and Metabolomics
• Cardiovascular Disease Research
• Biomarker Discovery

Background:

• Established links exist between metabolic disorders and coronary heart disease (CHD).
• Causal evidence connecting specific metabolites to CHD is limited.
• Bidirectional Mendelian Randomization (MR) is employed to investigate these causal relationships.

Purpose of the Study:

• To determine the causal effect of blood metabolites on coronary heart disease (CHD) risk.
• To explore the potential of metabolites as biomarkers for CHD.
• To integrate genomic and metabolomic data for novel insights into CHD pathogenesis.

Main Methods:

• Utilized genome-wide association study (GWAS) data for 1,400 metabolites.
• Employed bidirectional Mendelian Randomization (MR) with inverse variance weighting (IVW).
• Conducted sensitivity analyses, reverse MR, replication, meta-analysis, Steiger, and colocalization tests for robust causality assessment.

Main Results:

• Identified eight metabolites associated with lipids, amino acids, and metabolite ratios that may impact CHD risk.
• Specific metabolites like 1-oleoyl-2-arachidonoyl-GPE and Glycocholenate sulfate showed significant associations.
• Findings provide quantitative estimates (ORs and CIs) for the causal influence of these metabolites on CHD.

Conclusions:

• Genomic and metabolomic integration provides new perspectives on CHD development.
• Identified metabolites hold potential significance for CHD screening and prevention strategies.
• This research strengthens the understanding of metabolic influences on cardiovascular health.